Presynaptic, release-regulating mGlu2 -preferring and mGlu3 -preferring autoreceptors in CNS: pharmacological profiles and functional roles in demyelinating disease

British Journal of Pharmacology
Silvia Di PriscoAnna Pittaluga

Abstract

Presynaptic, release-regulating metabotropic glutamate 2 and 3 (mGlu2/3) autoreceptors exist in the CNS. They represent suitable targets for therapeutic approaches to central diseases that are typified by hyperglutamatergicity. The availability of specific ligands able to differentiate between mGlu2 and mGlu3 subunits allows us to further characterize these autoreceptors. In this study we investigated the pharmacological profile of mGlu2/3 receptors in selected CNS regions and evaluated their functions in mice with experimental autoimmune encephalomyelitis (EAE). The comparative analysis of presynaptic mGlu2/3 autoreceptors was performed by determining the effect of selective mGlu2/3 receptor agonist(s) and antagonist(s) on the release of [(3)H]-D-aspartate from cortical and spinal cord synaptosomes in superfusion. In EAE mice, mGlu2/3 autoreceptor-mediated release functions were investigated and effects of in vivo LY379268 administration on impaired glutamate release examined ex vivo. Western blot analysis and confocal microscopy confirmed the presence of presynaptic mGlu2/3 receptor proteins. Cortical synaptosomes possessed LY541850-sensitive, NAAG-insensitive autoreceptors having low affinity for LY379268, while LY541850-ins...Continue Reading

References

Mar 1, 1974·European Journal of Pharmacology·M RaiteriG Levi
Jan 1, 1995·Neuropharmacology·J P Pin, R Duvoisin
Aug 11, 2000·Journal of Neurochemistry·J Cartmell, D D Schoepp
Jun 12, 2003·Trends in Neurosciences·Michal SchwartzHadas Schori
Jun 14, 2003·Brain : a Journal of Neurology·J J G GeurtsE Aronica
Mar 18, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Deanna L TaylorJennifer M Pocock
May 16, 2007·Journal of Neurology·Michael LanzHelmut Hildebrandt
Apr 19, 2008·Journal of Neurochemistry·Fleur Pinteaux-JonesJennifer M Pocock
Nov 21, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Veronica MusanteAnna Pittaluga
Mar 17, 2009·Neuropharmacology·Anne-Cécile FrickerJames N C Kew
Mar 20, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Diego CentonzeGianvito Martino
Jul 3, 2009·Nature Reviews. Neuroscience·Peter W Kalivas
Jan 9, 2010·Annual Review of Pharmacology and Toxicology·Colleen M Niswender, P Jeffrey Conn
Jul 24, 2010·British Journal of Pharmacology·Carol KilkennyUNKNOWN NC3Rs Reporting Guidelines Working Group
Jul 27, 2010·Nature Medicine·Francesca FallarinoRoberto Di Marco
Sep 10, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Etienne DoumazaneJean-Philippe Pin
Nov 3, 2010·Neuropharmacology·F NicolettiJ P Pin
Dec 24, 2010·Journal of Neurochemistry·Marco MilaneseGiambattista Bonanno
Jul 12, 2011·Journal of Neurochemistry·Joseph H Neale
Nov 9, 2011·British Journal of Pharmacology·Stephen P H AlexanderJohn A Peters
Mar 6, 2012·Journal of Neurochemistry·Silvia Di PriscoAnna Pittaluga
May 9, 2012·Neuropharmacology·Maria SummaAnna Pittaluga
Nov 22, 2012·Proceedings of the National Academy of Sciences of the United States of America·Kristen A RahnAdam I Kaplin
Nov 16, 2013·Nucleic Acids Research·Adam J PawsonUNKNOWN NC-IUPHAR

❮ Previous
Next ❯

Citations

Sep 16, 2016·Frontiers in Pharmacology·Anna Pittaluga
Jul 28, 2019·International Journal of Molecular Sciences·Anna Pittaluga

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.